Insulin, intermediate and long-acting

PheWeb

INSULIN_INTER_AND_LONG

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC A10AE01|A10AE0[4-6]|A10AE30

17913

Check pre-conditions, main-only, mode, ICD version None

16598

Check minimum number of events

Min. number of events 3

16598

Include endpoints None

16598

INSULIN_INTER_AND_LONG

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Insulin, intermediate and long-acting based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	16098	6907	9191
Unadjusted prevalence (%)	5.22	3.98	6.81
Mean age at first event (years)	52.49	50.09	54.30

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.06	4.84 [4.09, 5.73]	8.6e-75	1964
15 years	0.01	2.57 [2.15, 3.06]	8.5e-26	979
5 years	0.01	5.45 [4.65, 6.40]	2.7e-96	875
1 year	0.00	3.36 [2.65, 4.25]	7.9e-24	108

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: INSULIN_INTER_AND_LONG – Insulin, intermediate and long-acting
GWS hits:

Survival analyses between endpoints

↥

Plot

before Insulin, intermediate and long-acting
after Insulin, intermediate and long-acting

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Insulin, intermediate and long-acting

↥